Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3888 Outcome of typical and atypical carcinoids after surgical resection – A single center retrospective study

Introduction: Typical (TC) and atypical carcinoids (AC) are rare malignant neoplasms.

Conference:

Presenting Author: Rubino M

Authors: Rubino M, Girelli L, Pisa E, Gervaso L, Spada F,

Keywords: lung carcinoid, primary surgery, recurrence rate, overall survival,

#3569 Outcomes of Streptozotocin (STZ)-based chemotherapy (CT) in patients with advanced pancreatic neuroendocrine tumors (pNETs): Data from the Spanish Taskforce of Neuroendocrine and Endocrine Tumors (GETNE) national registry (R-GETNE)

Introduction: STZ-based CT has been used for advanced pNETs with rapid growth, high tumor load or progression to somatostatin analogues (SSA). Evidence supporting use of STZ-based CT in pNET is mainly retrospective, and there is an unmet need of prospective trials in this setting. We present data from the R-GETNE regarding the use of STZ in spanish centers.

Conference:

Presenting Author:

Authors: Esteban-Villarrubia J, Hernando J, Garcia A, Jimenez-Fonseca P, Teulé A,

Keywords: Streptozotocin, Chemotherapy, pNET, GETNE, R-GETNE,

#3331 Outcomes of upfront treatment with mFOLFIRINOX regimen in G3 GEP-NENs: A monocentric retrospective experience

Introduction: To date outcomes of standard chemotherapy are not homogeneous in different subgroups of G3 GEP-NENs and remain unsatisfactory and poor; new therapeutic options are desirable in this setting.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Borghesani M

Authors: Borghesani M, Reni A, Zaninotto E, Fumagalli A, Benini L,

Keywords: net, mfolfirinox, chemotherapy, g3, minen,

#795 Efficacy of Octreotide LAR (OCT) in Patients (pts) with Advanced Neuroendocrine Tumors (NET): A Subgroup Analysis of Phase III RADIANT-2 Study with Updated Overall Survival (OS)

Introduction: OCT has shown antitumor activity and significantly prolonged time to tumor progression vs PBO in pts with metastatic midgut NET (PROMID).

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Strosberg J

Authors: Strosberg J, Yao J, Bajetta E, Aout M, Bakker B,

Keywords: neuroendocrine tumors, octreotide LAR, PFS,